NB
DFTX

NBT Bank’s Definium Therapeutics DFTX Stock Holding History

NBT Bank’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6
Closed -$80 – 1061
2025
Q4 		$80 Hold
6
– – ﹤0.01% 809
2025
Q3 		$71 Hold
6
– – ﹤0.01% 805
2025
Q2 		$39 Hold
6
– – ﹤0.01% 791
2025
Q1 		$35 Hold
6
– – ﹤0.01% 802
2024
Q4 		$42 Hold
6
– – ﹤0.01% 775
2024
Q3 		$34 Buy
+6
New +$42 ﹤0.01% 827

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NBT Bank's DFTX Position: Q1 2026 in Review

NBT Bank sold out of Definium Therapeutics (DFTX) in Q1 2026, closing a stake of 6 shares — an estimated $80 sold.

NBT Bank first reported a position in DFTX in Q3 2024 and held it in 6 quarters. The position peaked at $80 in Q4 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • NBT Bank reported no remaining Definium Therapeutics position as of Q1 2026 after selling out during the quarter.
  • NBT Bank sold 6 Definium Therapeutics shares in Q1 2026, an estimated $80.
  • NBT Bank first reported a position in Definium Therapeutics in Q3 2024 and held it in 6 quarters.
  • NBT Bank's Definium Therapeutics position peaked at $80 in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.